Plain-English translation of NCT07502677 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing a device called SleepImage that monitors your heart and breathing patterns while you sleep to see if it can reliably detect respiratory failure in ALS patients. The device measures how your heart rate and breathing synchronize during different stages of sleep. This technology has already been approved by the FDA and could help doctors catch breathing problems earlier in ALS, when they may still be treatable.
People with ALS often develop serious breathing problems that can be hard to detect early using standard oxygen monitors. This study exists to see whether the SleepImage device can catch these breathing problems sooner and more accurately, potentially allowing doctors to start life-supporting treatments before a crisis occurs.
You likely qualify if…
You likely don't qualify if…
You would wear the SleepImage monitoring device while you sleep. The device uses sensors to track your heart rate and breathing patterns throughout the night and analyzes the information to look for signs of breathing problems. The research team would then compare the device's findings with standard medical tests to see how accurate it is.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United Kingdom
Enrollment target
~15 participants
Started
March 2026
Primary completion
September 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Professor Michael Polkey
Royal Brompton & Harefield NHS Foundation Trust
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.